Prescribing behaviour according to Dutch and European guidelines on the management of hypercholesterolaemia (1992-1999)

Autor: Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Hofman, Albert, Verschuren, W M Monique, Trienekens, Paul H, Porsius, Arijan J, Stricker, Bruno H Ch, de Boer, Anthonius, Dep Farmaceutische wetenschappen, Sub Pharmacotherapy, Theoretical

Publikováno v: British Journal of Clinical Pharmacology, 61(5), 592. NLM (Medline)
British Journal of Clinical Pharmacology, 61(5), 592-600. Wiley-Blackwell Publishing Ltd

Background The success of the full implementation of a new guideline may depend on the observed discrepancy between daily medical practice developed before the release of the guideline and new treatment recommendations issued by the guideline. Aim To

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223eb6976de689805e9e21bb08c2b39b
https://doi.org/10.1111/j.1365-2125.2006.02634.x

Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin

Autor: Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Egberts, Toine C G, Verschuren, W M Monique, Porsius, Arijan J, de Boer, Anthonius, Dep Farmaceutische wetenschappen, Sub Pharmacotherapy, Theoretical, Sub Clinical Pharmacy, Pharmacoepi

Publikováno v: Drug Safety, 27(1), 63. Springer International Publishing Switzerland

BACKGROUND: Persistence with lipid-lowering drug use is important in order for patients to gain full treatment benefit. The withdrawal of cerivastatin from the market may have affected persistence due to the fear of serious adverse effects. OBJECTIVE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4e34d761838ae5c065ba18727c0f3b88
https://dspace.library.uu.nl/handle/1874/396967

Myopathy due to statin/fibrate use in the Netherlands

Autor: Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Herings, Ron M C, van Puijenbroek, Eugène P, Porsius, Arijan J, de Boer, Anthonius, Dep Farmaceutische wetenschappen, Sub Pharmacotherapy, Theoretical

Publikováno v: Annals of Pharmacotherapy, 36(12), 1957. Harvey Whitney Books Company

OBJECTIVE: To estimate the number of expected cases of myopathy based on the prevalence of lipid-lowering drug use, and to compare this number with the observed number of cases of myopathy due to lipid-lowering drug use in the Netherlands. METHODS: P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::d9ee3869a3b2d1e5eda06fee5ffe38cb
https://dspace.library.uu.nl/handle/1874/396845

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa

Autor: van de Vijver, D A M C, Roos, R A C, Jansen, P A F, Porsius, A J, de Boer, A, Dep Farmaceutische wetenschappen, Sub Pharmacotherapy, Theoretical, LS Ges. van de bouwkunst, Sub Biomol.Mass Spectrometry & Proteom.

Publikováno v: British Journal of Clinical Pharmacology, 54(2), 168. NLM (Medline)

AIMS: We determined whether the start of selective serotonin reuptake inhibitors (SSRI) in levodopa users was followed by a faster increase of antiparkinsonian drug treatment. METHODS: Selected were all levodopa users of 55 years and older from the P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::eef509e32d201edaacf326672fef64b0
https://dspace.library.uu.nl/handle/1874/27876

Determinants of undertreatment of hypercholesterolaemia in a population-based study in The netherlands

Autor: Mantel-Teeuwisse, A K, Verschuren, W M M, Klungel, O H, Porsius, A J, de Boer, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::bdeb64e3e77e3a531c9c3ad064385375
https://europepmc.org/articles/PMC1874355/